Artivion to Participate in Upcoming Investor Conferences
ATLANTA, Oct. 28, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences. Artivion's management team will present at the upcoming Stifel 2026...
Covered in this story
Call it yourself
No calls on $AORT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Artivion Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.